Objective: To assess the clinical indications and spectrum of MDP bone scan findings in paediatric patients referred to the National 
INTRODUCTION
The radionuclide bone imaging using Tc MDP for planar bone scan. Single photon emission computed tomography (SPECT) provides improved spatial resolution of imaging using gamma emitters and, moreover, it can be fused with MRI and CT, thus giving anatomic dimension to nuclear medicine imaging (6) . No published data on the incidence of paediatric cancer is available in Bangladesh. paediatric cancer or childhood cancer means cancer in children which are rare and representing between 0.5% and 4.6% of all cancers. Cancer is the second most common cause of death in children, accounting for approximately 10% of all childhood deaths. The overall incidence rates of childhood cancer vary between 50 and 200 per million children across the world (7, 8) .
This retrospective study was performed to assess the spectrum of MDP bone scan findings and nature of clinical indications of MDP skeletal survey in paediatric patients referred to a tertiary centre.
MATERIALS AND METHODS
This retrospective study was carried out in National Institute of Nuclear Medicine and Allied Sciences, Dhaka, from January 2014 to November 2015. Total 2323 bone scans were performed at NINMAS and out of them 91 paediatric patients were enrolled (48 males and 43 females, age range 2-18 years, mean age 11.37 ± 4.91 years) in this study. All paediatric patients between 0-18 years of age referred for bone scan with various clinical indications were included in this study. The WHO recommended standard age of paediatric patient is 0-18 years (9) . Whole body bone scan was performed on anterior and posterior projections in each patient after intravenous injection of 99m Tc MDP. If needed, three phase bone scan and spot views were obtained by using Siemens E.cam dual head gamma camera. The available clinical data, detail history and related investigation results and imaging findings were recorded from the departmental data archiving system. Images of all patients were reviewed and interpreted by at least two senior nuclear medicine specialists. The spectrum of clinical indications of bone scan and nature of scan findings were recorded for analysis.
RESULTS
Total 91 paediatric patients, 48 males and 43 females (Table 1) , age range 2-18 years, mean age 11.37 ± 4.91 years were referred for radionuclide skeletal survey with various clinical indications which were predominantly malignant. The most common clinical indications were osteosarcoma 30 (32.96%) cases and Ewing's sarcoma 25 (27.47%) cases followed by five (5.49%) neuroblastoma, four (4.39%) rhabdomyosarcoma, three (3.29%)
Langerhans cell histocytosis and rest others ( Table 2) .
Bone scan was positive in 58(63.7%) cases and normal in 33(36.3%) cases (Table 3) . Out of 58 cases 38 cases had features of primary bony lesion, 10 cases had multiple metastases, among four cases had primary bone tumour of Ewing's sarcoma with metastases and solitary bone lesion suspicious for metastasis were present in three cases (Table 4 ). The childhood tumour was present in 69 cases with osteosarcoma predominance and the distribution of childhood tumour in different age group is summarized in Table 5 . Metastatic bone involvement was more prevalent in Ewing's sarcoma; in 24% cases comparing to osteosarcoma, which was 13.3%. Distribution of bony lesion according to the skeletal site of involvement shown in Table 6 , where appendicular bony involvement was predominant (60.35%). Bone scan is the investigation next to radiography for the osteomyelitis, septic arthritis and trauma. It is recommended when the radiological evaluations are negative. The sensitivity of three phase bone scan is 95% for the osteomyelitis with reported accuracy of 75 % or better and useful in differentiating osteomyelitis from cellulitis (17).
CONCLUSION
Bone scan in paediatric patients contributes a major role in detecting the cause and localizing the pathology of bone. It is a popular imaging modality for skeletal survey of paediatric patients in malignancy, both primary and metastatic bone diseases. High quality imaging, interpreted by physicians familiar with paediatric diseases, correlation with clinical records and other imaging modalities are mandatory to maximize the benefit.
